Literature DB >> 4743075

The induction of ovulation by tamoxifen.

J G Williamson, J D Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4743075     DOI： 10.1111/j.1471-0528.1973.tb11230.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Br Commonw        ISSN： 0022-3204


× No keyword cloud information.
  14 in total

Review 1.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

2.  Comparison between tamoxifen and clomiphene therapy in women with anovulation.

Authors:  I Gerhard; B Runnebaum
Journal:  Arch Gynecol       Date:  1979

3.  The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

Review 4.  History and challenges surrounding ovarian stimulation in the treatment of infertility.

Authors:  Stephanie A Beall; Alan DeCherney
Journal:  Fertil Steril       Date:  2012-04       Impact factor: 7.329

5.  Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).

Authors:  Carolyn D Runowicz; Joseph P Costantino; D Lawrence Wickerham; Reena S Cecchini; Walter M Cronin; Leslie G Ford; Victor G Vogel; Norman Wolmark
Journal:  Am J Obstet Gynecol       Date:  2011-06-24       Impact factor: 8.661

Review 6.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

Review 7.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 8.  Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 9.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

Review 10.  The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.

Authors:  Philipp Y Maximov; Theresa M Lee; V Craig Jordan
Journal:  Curr Clin Pharmacol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.